Fate Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Highlights Operational Progress

Go back to Fate Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Highlights Operational Progress
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.16 --0 (-0%)
Previous Close $2.16    52 Week High $4.76 
Open $2.16    52 Week Low $1.46 
Day High $2.16    P/E N/A 
Day Low $2.16    EPS $-1.91 
Volume 212,979